Ariston Pharma Nova Tech Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Under Liquidation
Last Updated:
Access Report
About Ariston Pharma Nova Tech Private Limited

Ariston Pharma Nova Tech Private Limited, a under liquidation private limited company, was established on 19 October 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2012PTC083734. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.70 M.

It upholds a compliant status. Employing 24 professional, Its leadership includes Vedprakash Vyas (Director), Rajesh Chillale (Irp/Rp/Liquidator), Subhash Goverdhandasji Bissa (Director). Past directors included Viswanath Konala, Algatoori Bhavani, Srinivas Korkonda. It holds ₹6.09 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at D No.5-5-35/136/B, Ground Floor Prasanthi Nagar, Ida, Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PTC083734

  • Registration Number

    083734

  • Incorporation Date

    19 October 2012

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹6.70 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 6.70 M
  • Company Age 13 Year, 4 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 6.09 Cr
  • Revenue Growth **** -46.56%
  • Profit Growth **** -75.75%
  • Ebitda **** -21.30%
  • Net Worth 3.26%
  • Total Assets -3.78%
Company report

Ariston Pharma Nova Tech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ariston Pharma Nova Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ariston Pharma Nova Tech Private Limited?
Current Directors
Name Designation Appointment Date Status
Vedprakash Vyas Director 19 Oct 2012 Current
Rajesh Chillale Irp/Rp/Liquidator 24 May 2024 Current
Subhash Goverdhandasji Bissa Director 25 Sep 2019 Current
Shankar Sharma Director 16 Oct 2024 Current
Rounak Sharma Director 16 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Mar 2014 Past
Pramod Abcsdd Director 20 Sep 2017 Past
Pramod Abcsdd Director 25 Mar 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 25 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ariston Pharma Nova Tech.

Ariston Pharma Nova Tech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 46.56% decrease. The company also saw a substantial fall in profitability, with a 75.75% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.

Ariston Pharma Nova Tech revenue growth over time
Ariston Pharma Nova Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -46.56%
*******
*******
*******
*******
Revenue from Operations
*******
 -46.55%
*******
*******
*******
*******
Total Assets
*******
 -3.78%
*******
*******
*******
*******
Profit or Loss
*******
 -75.75%
*******
*******
*******
*******
Net Worth
*******
 3.26%
*******
*******
*******
*******
EBITDA
*******
 -21.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ariston Pharma Nova Tech?

In 2019, Ariston Pharma Nova Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹60,940,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Syndicate Bank : 6.09 Cr
Latest Charge Details
Date Lender Amount Status
28 Mar 2017 Syndicate Bank ₹0.94 M Open
09 Nov 2015 Syndicate Bank ₹6.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Ariston Pharma Nova Tech?

Ariston Pharma Nova Tech has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ariston Pharma Nova Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ariston Pharma Nova Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ariston Pharma Nova Tech
Recent Activity within the Organization
  • Director Appointment

    The activity Shankar Sharma was appointed as a Director was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    Progress on Rounak Sharma was appointed as a Director was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 4 months . was documented.

  • Director Appointment

    Rajesh Chillale was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 24 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Annual General Meeting

    The activity Ariston Pharma Nova Tech Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.

  • Director Appointment

    Subhash Goverdhandasji Bissa was appointed as a Director was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Balance Sheet

    Progress on Ariston Pharma Nova Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ariston Pharma Nova Tech Private Limited?

The CIN of Ariston Pharma Nova Tech Private Limited is U24232TG2012PTC083734.

Where is Ariston Pharma Nova Tech Private Limited headquartered?

Ariston Pharma Nova Tech Private Limited is headquartered at D No.5-5-35/136/B, Ground Floor Prasanthi Nagar, Ida, Kukatpally, Hyderabad, Telangana, 500072.

When was Ariston Pharma Nova Tech Private Limited incorporated?

Ariston Pharma Nova Tech Private Limited was incorporated on 19 October 2012.

Who are the current directors of Ariston Pharma Nova Tech Private Limited?

The current directors of Ariston Pharma Nova Tech Private Limited are

What is the primary industry of Ariston Pharma Nova Tech Private Limited?

The primary industry of Ariston Pharma Nova Tech Private Limited is Manufacturing.

Is Ariston Pharma Nova Tech Private Limited a listed company?

Ariston Pharma Nova Tech Private Limited is unlisted.

What is the capital structure of Ariston Pharma Nova Tech Private Limited?

The authorized capital of Ariston Pharma Nova Tech Private Limited is ₹1.00 Cr, and the paid-up capital is ₹6.70 M.

What is the compliance status of Ariston Pharma Nova Tech Private Limited?

The compliance status of Ariston Pharma Nova Tech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available